The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MERLIN_001: A prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic value for more accurate staging of patients with SN-negative melanoma.
 
Tina J. Hieken
Speakers' Bureau - Skyline Diagnostics
Research Funding - Genentech/Roche (Inst); Skyline Diagnostics (Inst)
 
Michael Earl Egger
Consulting or Advisory Role - Iovance Biotherapeutics
Research Funding - Skyline Diagnostics
 
Christina Vadala Angeles
Research Funding - Skyline Diagnostics (Inst)
 
Michael C. Lowe
Research Funding - Bristol-Myers Squibb (Inst); Delcath Systems (Inst); Regeneron (Inst); Vaccinex (Inst)
 
Erin E. Burke
Research Funding - Skyline Diagnostics (Inst)
 
Edmund Bartlett
Honoraria - Excite International
 
John Robert Hyngstrom
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Vernon K. Sondak
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Iovance Biotherapeutics; Merck/Schering Plough; Novartis; Regeneron
Research Funding - Neogene Therapeutics (Inst); Turnstone Bio (Inst)